# Atossa Therapeutics, Inc.: Form 8-K, filed Jul 2, 2024

- Company: [Atossa Therapeutics, Inc.](/companies/atos.md) (CIK 1488039)
- Form: 8-K
- Filed: 2024-07-02
- Accepted by EDGAR: Jul 2, 2024, 20:20 ET
- Period: 2024-06-27
- Accession: 0000950170-24-080497
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1488039/000095017024080497/atos-20240627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1488039/000095017024080497/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1488039/000095017024080497/atos-20240627.htm

Filed Jul 2, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-080497. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.